Companies: 10,795·Total market cap: $144.5T
Annexon, Inc.

Annexon, Inc.

ANNXNASDAQHealthcare● Active
$5.18
$-0.12(-2.17%)
Market Cap$618904389
P/E Ratio—
52W High$7.18
52W Low$1.85
Cash on HandFinancialsRevenue

Annexon, Inc. (ANNX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ANNX · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$238.3M▼ -23.6% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$162.1M
cashAndCashEquivalents
Short-Term Investments
$76.3M
shortTermInvestments
YoY Change vs Prior Year
-23.6%
vs prior fiscal year
Latest Quarter
$225.0M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$238.3MCash on Hand
Total Debt$26.2MTotal Debt
Net Cash / Net Debt+$212.1MNet Cash Position
Cash vs Debt Ratio
Cash 90%Debt 10%

Annexon, Inc. has a net cash position of $212.1M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$238.3M − $26.2M = +$212.1M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ANNX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$238.3M-23.6%
Dec 31, 2024$312.0M+20.1%
Dec 31, 2023$259.7M+7.0%
Dec 31, 2022$242.7M+0.0%
Dec 31, 2021$242.7M-30.9%
ANNX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Annexon, Inc.
Annexon, Inc.YOU
ANNX
$238.3M39.0%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Annexon, Inc. (ANNX) cash on hand as of December 31, 2025 is $238.3M, comprising $162.1M in cash and cash equivalents (CCE) plus $76.3M in short-term investments — reported as Annexon, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Annexon, Inc. cash reserves or cash position.

Annexon, Inc. annual cash on hand history shows decreased -23.6% in 2025: decreased -23.6% in 2025. Annexon, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Annexon, Inc. carries total debt of $26.2M against cash of $238.3M, resulting in a net cash position of +$212.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ANNX cash on hand · 5 questions

As of December 31, 2025, Annexon, Inc. (ANNX) has $238,345,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $162,051,000 in cash and cash equivalents (CCE) plus $76,294,000 in short-term investments. Latest quarter (March 31, 2026): $225,025,000. Data sourced from the annual 10-K filing via FMP.

ANNX cash on handANNX cash reservesANNX cash 2025how much cash does ANNX have

▸ Source: FMP /balance-sheet-statement · US GAAP · Annexon, Inc. · Annexon, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025